SAT · Class II · 21 CFR 870.2380

FDA Product Code SAT: Pulmonary Hypertension Machine Learning-based Notification Software

Pulmonary Hypertension Machine Learning-based Notification Software Employs Machine Learning Techniques To Suggest The Likelihood Of Pulmonary Hypertension For Further Referral Or Diagnostic Follow-up.

Leading manufacturers include Analytics For Life, Inc. and Anumana, Inc..

2
Total
2
Cleared
192d
Avg days
2024
Since
Stable submission activity - 1 submissions in the last 2 years
Review times increasing: avg 242d recently vs 142d historically

FDA 510(k) Cleared Pulmonary Hypertension Machine Learning-based Notification Software Devices (Product Code SAT)

2 devices
1–2 of 2

About Product Code SAT - Regulatory Context

510(k) Submission Activity

2 total 510(k) submissions under product code SAT since 2024, with 2 receiving FDA clearance (average review time: 192 days).

Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.

FDA Review Time

Recent submissions under SAT have taken an average of 242 days to reach a decision - up from 142 days historically. Manufacturers should account for longer review timelines in current project planning.

SAT devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →